SCM
Soleus Capital Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-99,050
| Closed | -$8.11M | – | 86 |
|
|
2024
Q4 | $8.11M | Buy |
99,050
+72,000
| +266% | +$5.89M | 0.51% | 45 |
|
|
2024
Q3 | $3.09M | Sell |
27,050
-158,200
| -85% | -$18.1M | 0.24% | 71 |
|
|
2024
Q2 | $14M | Sell |
185,250
-22,500
| -11% | -$1.7M | 1.23% | 30 |
|
|
2024
Q1 | $14.2M | Sell |
207,750
-207,700
| -50% | -$14.2M | 1.05% | 28 |
|
|
2023
Q4 | $26.1M | Sell |
415,450
-84,200
| -17% | -$5.29M | 2.89% | 13 |
|
|
2023
Q3 | $25.5M | Sell |
499,650
-71,600
| -13% | -$3.65M | 2.35% | 9 |
|
|
2023
Q2 | $28.5M | Buy |
571,250
+191,000
| +50% | +$9.54M | 3.17% | 9 |
|
|
2023
Q1 | $14.3M | Sell |
380,250
-7,700
| -2% | -$289K | 1.48% | 19 |
|
|
2022
Q4 | $18.6M | Buy |
387,950
+52,300
| +16% | +$2.51M | 2.67% | 12 |
|
|
2022
Q3 | $8.06M | Sell |
335,650
-35,000
| -9% | -$840K | 1.09% | 28 |
|
|
2022
Q2 | $8.07M | Buy |
370,650
+42,300
| +13% | +$920K | 1.26% | 27 |
|
|
2022
Q1 | $7.93M | Buy |
328,350
+33,600
| +11% | +$811K | 1.02% | 32 |
|
|
2021
Q4 | $7.01M | Sell |
294,750
-60,900
| -17% | -$1.45M | 0.7% | 29 |
|
|
2021
Q3 | $9.02M | Sell |
355,650
-20,000
| -5% | -$507K | 1.41% | 23 |
|
|
2021
Q2 | $8.46M | Buy |
375,650
+82,000
| +28% | +$1.85M | 1.3% | 22 |
|
|
2021
Q1 | $5.8M | Buy |
+293,650
| New | +$5.8M | 1.05% | 18 |
|